{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/aminosalicylic-acid-2",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/aminosalicylic-acid-2#bnf_i1643857925308",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/aminosalicylic-acid-2#bnf_i1643857925308_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"aminosalicylic acid\" outputclass=\"int-heading-drug\">Aminosalicylic acid</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of methaemoglobinaemia when given with</ph> <ph otherprops=\"dapsone\" outputclass=\"int-drug\">dapsone</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Aminosalicylic acid   is predicted to   increase   the risk of methaemoglobinaemia when given with   dapsone .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dapsone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/aminosalicylic-acid-2#bnf_i1643857925309",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/aminosalicylic-acid-2#bnf_i1643857925309_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"aminosalicylic acid\" outputclass=\"int-heading-drug\">Aminosalicylic acid</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of methaemoglobinaemia when given with</ph> <ph outputclass=\"int-route\">topical</ph> <ph otherprops=\"prilocaine\" outputclass=\"int-drug\">prilocaine</ph>. <ph outputclass=\"int-action\">Manufacturer advises use with caution or avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Aminosalicylic acid   is predicted to   increase   the risk of methaemoglobinaemia when given with   topical   prilocaine .  Manufacturer advises use with caution or avoid .    \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Prilocaine</title>"
					}
				}
			],
			"hasSearchLabel": " Aminosalicylic acid  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/aminosalicylic-acid-2.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Aminosalicylic acid </title>"
			},
			"rdfs:label": "aminosalicylic acid"
		}
	]
}